These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26777320)

  • 1. Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.
    Haque M; Song J; Fino K; Sandhu P; Wang Y; Ni B; Fang D; Song J
    Cell Transplant; 2016; 25(5):811-27. PubMed ID: 26777320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
    Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed differentiation of induced pluripotent stem cells towards T lymphocytes.
    Lei F; Haque R; Xiong X; Song J
    J Vis Exp; 2012 May; (63):e3986. PubMed ID: 22617911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Tumor Antigen-Specific Cytotoxic T Lymphocytes from Pluripotent Stem Cells.
    Chen X; Lei F; Wang L; Xiong X; Song J
    Methods Mol Biol; 2019; 1884():43-55. PubMed ID: 30465194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells.
    Xiong X; Das JK; Song J; Ni B; Ren X; Yang JM; Song J
    Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 29986440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Differentiation of T Cells from Murine Pluripotent Stem Cells.
    Chen X; Lei F; Wang L; Xiong X; Song J
    Methods Mol Biol; 2019; 2048():131-141. PubMed ID: 31396937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of naive single-type tumor antigen-specific CD8
    Lei F; Haque M; Sandhu P; Ravi S; Song J; Ni B; Zheng S; Fang D; Jia H; Yang JM; Song J
    Oncoimmunology; 2017; 6(7):e1334027. PubMed ID: 28811978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein.
    Kalbasi A; Shrimali RK; Chinnasamy D; Rosenberg SA
    J Immunother; 2010 Sep; 33(7):672-83. PubMed ID: 20664359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor gene therapy of established tumors in a murine melanoma model.
    Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA
    J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector cells derived from naive T cells used in tumor immunotherapy of mice bearing B16 melanoma.
    Wen M; Xu W; Ren L; Gao F; Cui N; Wen J; Li X; Lin L; Ma Z; Chen B; Cai J
    Chin Med J (Engl); 2014; 127(7):1328-33. PubMed ID: 24709189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.
    Quatromoni JG; Morris LF; Donahue TR; Wang Y; McBride W; Chatila T; Economou JS
    J Hematol Oncol; 2011 Nov; 4():48. PubMed ID: 22112546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment.
    Bathe OF; Dalyot-Herman N; Malek TR
    BMC Cancer; 2003 Jul; 3():21. PubMed ID: 12882650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
    Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
    J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.
    Kesarwani P; Chakraborty P; Gudi R; Chatterjee S; Scurti G; Toth K; Simms P; Husain M; Armeson K; Husain S; Garrett-Mayer E; Vasu C; Nishimura MI; Mehrotra S
    Oncotarget; 2016 Oct; 7(43):69371-69383. PubMed ID: 27750220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.
    Kerkar SP; Sanchez-Perez L; Yang S; Borman ZA; Muranski P; Ji Y; Chinnasamy D; Kaiser AD; Hinrichs CS; Klebanoff CA; Scott CD; Gattinoni L; Morgan RA; Rosenberg SA; Restifo NP
    J Immunother; 2011 May; 34(4):343-52. PubMed ID: 21499127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
    Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.